AUXILIUM BIOTECHNOLOGIES INC.
San Diego, CA · Founded 2019 · CIK 0001800618 · Medtech · Private
NeuroSpan Bridge: a biomimetic multi-channel scaffold for peripheral nerve repair and axonal regeneration
- Grants
- $1.0M
- 1 award
- Sector median: 1
- Raised
- $6.8M
- 2 Form D · Oct 2025
- 11 months since last filing
- Contracts
- $6.9M
- 3 awards · NASA
- #92 of 4531 in medtech
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,249,988 | |
| Federal contract | National Aeronautics and Space Administration · Biomanufacturing In Space Of Drug-delivery Medical Devices | $4,673,184 | |
| Federal grant | Department of Health and Human Services · Phase I · The Neurospan Bridge: A Device for Peripheral Nerve Repair | $1,000,000 | |
| Federal contract | National Aeronautics and Space Administration · SBIR I Auxilium Microfabrication Platform Cartridge Modification | $146,794 | |
| Private capital raised | Form D · SEC | $3,536,015 | |
| Federal contract | National Aeronautics and Space Administration · Auxilium Phase 2 | $2,068,750 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 89 | IRIDEX CORP | $7.5M | $10M |
| 90 | MATREGENIX INC | $7.1M | — |
| 91 | THE DNA MEDICINE INSTITUTE, INC. | $7.1M | — |
| 92 | AUXILIUM BIOTECHNOLOGIES INC. | $6.9M | $6.8M |
| 93 | Veracyte | $6.8M | $22M |
| 94 | SONIVATE MEDICAL, INC. | $6.7M | $1.4M |
| 95 | AMSEL MEDICAL CORPORATION | $6.6M | $40K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Craig AndrewsDirector
- Donald CohnDirector
- Robert EnglerDirector
- Yacov KofflerDirector · Executive Officer
- Mark TuszynskiDirector
Patents
- Tissue Repair Scaffolds With Improved Features For Implantationapplication
- Dynamic Microfabrication Through Digital Photolithography System And Methodsapplication
- Tissue Repair Scaffolds With Improved Features For Implantationapplication
- Dynamic Microfabrication Through Digital Photolithography System And Methodsapplication
- Tissue Repair Scaffolds With Improved Features For Implantationapplication
- Systems And Methods For Micromanufacturing And Bioprinting In A Micro Gravity Environment Thereofapplication
- Dynamic Microfabrication Through Digital Photolithography System And Methodsapplication
- Systems And Methods For Micromanufacturing And Bioprinting In A Micro Gravity Environment Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.